CzbnAuto® Female Autologous Reproductive Stem Cells
Product Specifications
| ID | Product Specifications | Product Name |
|---|---|---|
| Czbn-ASC004 | 0.1-2×10⁸ | CzbnAuto® Female Autologous Reproductive Stem Cells |
Stem Cell Attributes
Multipotent stem cells: specialized for the germ cell lineage.

Core Features
Self-update
Maintains stem cell proliferation in vitro.
Differentiation potential
In vitro, it can be induced to differentiate into oocyte precursor cells, theoretically replenishing the ovarian follicle reserve.
Ovarian Microenvironment Regulation
Secreted factors support granulosa cell growth and help maintain ovarian tissue homeostasis.
Transform Application Research Directions
The following content is compiled based on the biological characteristics of female autologous reproductive stem cells and publicly available research for educational purposes only; it does not constitute medical advice. Related clinical applications must be conducted in accredited healthcare facilities in compliance with applicable laws and regulations.
Research on Repairing Premature Ovarian Failure (POF) and Premature Ovarian Insufficiency (POI)
Research focuses on the potential to repair damaged ovarian tissue, improve the ovarian microenvironment, promote follicular development, and restore endocrine function, while exploring interventions to regulate menstrual cycles and support natural conception.
Intervention Studies for Polycystic Ovary Syndrome (PCOS)
Explore ways to improve the ovarian microenvironment, promote follicle development, and enhance insulin sensitivity to support ovulation and boost fertility.
Research on Ovarian Aging and Alleviation of Menopausal Symptoms
Research focuses on its role in supporting ovarian hormone (estrogen and progesterone) secretion, alleviating menopausal symptoms such as hot flashes and insomnia, and delaying ovarian aging.
Why Choose Chunzhu: The Century-Long Life Bank
Third-generation iPSC small-molecule transdifferentiation technology derived from Nobel Prize-winning research
- No gene editing involved, ensuring greater safety.
- Generate autologous reproductive stem cells from blood cell transformation
- Exhibits potential for reproductive lineage-directed differentiation, aligning with women's reproductive health management.
Six Core Advantages
- Draw 80-150 ml of blood; complete library construction within 6-10 days.
- Autologous cell source with low risk of immune rejection and no gene editing involved.
- Store for all ages; produce functional cells on demand
Empowering the Human Genetic Resources Platform
- Platform inbound management, end-to-end sample monitoring and traceability
- Companion AI health simulation and clinical reference plans
Cooperative Consortium of the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
- Sync cutting-edge research findings
- Accelerate technology iteration and clinical research advancement
End-to-end workflow: Preparation · Storage · Tertiary Hospital Clinical Integration
- Beyond just storing cells, we enable seamless access and usage.
- Support future clinical translation and implementation
Three steps to storage
Blood Collection and Sampling
80-150ml blood sample collection
GMP Laboratory Library Preparation
Cell preparation and library construction completed in 6-10 days
-196°C Liquid Nitrogen Long-Term Deep-Freeze Storage
Long-term storage and on-demand production of targeted functional cells
This page provides educational information on stem cell science and our company's R&D directions. It does not constitute medical advice or a guarantee of treatment outcomes. For specific applications, please follow the guidance of qualified healthcare professionals.
